IShares NASDAQ US Biotechnology UCITS ETF: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei iShares NASDAQ US Biotechnology UCITS ETF listata cu simbolul DE.2B70 ==Descriere companie== The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease. The dividends in the fund are reinvested (accumulating). The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most rel...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease. The dividends in the fund are reinvested (accumulating). | The [[Nasdaq]] Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease. The dividends in the fund are reinvested (accumulating). | ||
The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most relevant index constituents (sampling technique). The iShares Nasdaq US Biotechnology UCITS ETF has 322m GBP assets under management. The ETF is older than 3 years and is domiciled in Ireland. | The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most relevant index constituents (sampling technique). The iShares Nasdaq US Biotechnology UCITS ETF has 322m GBP assets under management. The ETF is older than 3 years and is domiciled in Ireland. | ||
Versiunea de la data 22 septembrie 2024 17:55
Pagina dedicata companiei iShares NASDAQ US Biotechnology UCITS ETF listata cu simbolul DE.2B70
Descriere companie
The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease. The dividends in the fund are reinvested (accumulating).
The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most relevant index constituents (sampling technique). The iShares Nasdaq US Biotechnology UCITS ETF has 322m GBP assets under management. The ETF is older than 3 years and is domiciled in Ireland.
Grafic actiuni companie